Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > p38 MAP Kinase Inhibitor Program > Compound (Co.: USA. S)

---

Compound (Co.: USA. S)'s subsections
Clinical Status: Phase IIa
Company:
Oral Availability

Compound (Co.: USA. S)'s products
This section has no products